Invion (AU:IVX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Invion Limited has successfully completed a consolidation of its securities, reducing the number of shares to streamline its issued capital with a ratio of 1 security for every 100. Trading has resumed under its original ASX ticker “IVX” following shareholder approval. This move is part of Invion’s ongoing efforts to optimize its financial structure while advancing its cutting-edge Photosoft technology in cancer treatment and infectious diseases.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Here Is a Look into the Boeing (NYSE:BA) Contract Offers That Ended Its Strike
- What If Elon Musk Actually Did Buy the Comcast (NASDAQ:CMCSA) Channels?
- Long John Silver: Pirate, Mutineer, and Personal Finance Guru?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
